EPAS1和2型糖尿病:一项双样本孟德尔随机化研究
EPAS1 and Type 2 Diabetes Mellitus: A Two-Sample Mendelian Randomization Study
DOI: 10.12677/acrem.2025.131005, PDF,   
作者: 龙若兰*, 李连新, 岳仁宋:成都中医药大学附属医院,四川 成都
关键词: EPAS1T2DM孟德尔随机化EPAS1 T2DM Mendelian Randomization
摘要: 目的:采用两样本孟德尔随机化分析法,探讨EPAS1与2型糖尿病(T2DM)的因果关联,以期为T2DM的防治提供新思路。方法:利用全基因组关联研究(GWAS)的数据,将EPAS1作为暴露因素,以T2DM为结局变量,进行孟德尔随机化分析。本研究以逆方差加权(IVW)法作为主要的MR分析手段,将单核苷酸多态性(SNP)的因果效应估计进行汇总合并,同时结合MR-Egger回归、加权中位数、加权模式作为补充方法分析二者之间的潜在因果关联。利用Cochran’s Q检验、MR-Egger回归截距、留一法进行敏感性分析。结果:IVW分析结果显示,EPAS1与T2DM之间存在显著的正向因果关联(OR: 1.055, 95% CI: 1.044~1.067, P = 6.96e−22)。敏感性分析显示不存在多效性,但异质性显著,结果相对可靠。结论:EPAS1与T2DM之间存在显著的正向因果关联,但需进行进一步验证。
Abstract: Aim: To explore the cause-and-effect relationship between EPAS1 and Type 2 Diabetes Mellitus (T2DM), a two-sample Mendelian randomization analysis was used to provide new ideas for the prevention and treatment of T2DM. Method: Using data from the Genome-Wide Association Study (GWAS), mendelian randomization analysis was performed with EPAS1 as an exposure factor and T2DM as an outcome variable. In this paper, Inverse Variance Weighting (IVW) was used as the primary analysis method to pool and combine the causal effect estimates of Single Nucleotide Polymorphisms (SNPs), and MR-Egger regression, weighted median, and weighted model were used as supplementary methods to analyze the potential causal association between the two. Cochran’s Q test, MR-Egger regression intercept, and leave-one-out method were used for sensitivity analysis. Results: IVW analysis showed that EPAS1 and T2DM had a significant positive causal relationship (OR: 1.055, 95% CI: 1.044~1.067, P = 6.96e–22). Sensitivity analysis showed no pleiotropy but significant heterogeneity, and the results were relatively reliable. Conclusion: EPAS1 and T2DM have a significant positive causal relationship, but further verification is needed.
文章引用:龙若兰, 李连新, 岳仁宋. EPAS1和2型糖尿病:一项双样本孟德尔随机化研究[J]. 亚洲急诊医学病例研究, 2025, 13(1): 25-32. https://doi.org/10.12677/acrem.2025.131005

参考文献

[1] Sun, H., Saeedi, P., Karuranga, S., Pinkepank, M., Ogurtsova, K., Duncan, B.B., et al. (2022) IDF Diabetes Atlas: Global, Regional and Country-Level Diabetes Prevalence Estimates for 2021 and Projections for 2045. Diabetes Research and Clinical Practice, 183, Article ID: 109119. [Google Scholar] [CrossRef] [PubMed]
[2] Peng, W., Li, K., Yan, A.F., Shi, Z., Zhang, J., Cheskin, L.J., et al. (2022) Prevalence, Management, and Associated Factors of Obesity, Hypertension, and Diabetes in Tibetan Population Compared with China Overall. International Journal of Environmental Research and Public Health, 19, Article 8787. [Google Scholar] [CrossRef] [PubMed]
[3] 张泽鑫, 罗樱樱, 刘林, 等. 拉萨地区藏族成年人群糖尿病前期及糖尿病患病率初步调查分析[J]. 中国糖尿病杂志, 2019, 27(8): 567-571.
[4] He, C., Zhu, B., Gao, W., Wu, Q. and Zhang, C. (2024) Study on Allele Specific Expression of Long-Term Residents in High Altitude Areas. Evolutionary Bioinformatics, 20, 1-6. [Google Scholar] [CrossRef] [PubMed]
[5] Missiaen, R., Lesner, N.P. and Simon, M.C. (2023) HIF: A Master Regulator of Nutrient Availability and Metabolic Cross‐Talk in the Tumor Microenvironment. The EMBO Journal, 42, e112067. [Google Scholar] [CrossRef] [PubMed]
[6] Kierans, S.J. and Taylor, C.T. (2020) Regulation of Glycolysis by the Hypoxia‐Inducible Factor (HIF): Implications for Cellular Physiology. The Journal of Physiology, 599, 23-37. [Google Scholar] [CrossRef] [PubMed]
[7] Peng, Y., Cui, C., He, Y., Ouzhuluobu,, Zhang, H., Yang, D., et al. (2017) Down-Regulation of EPAS1 Transcription and Genetic Adaptation of Tibetans to High-Altitude Hypoxia. Molecular Biology and Evolution, 34, 818-830. [Google Scholar] [CrossRef] [PubMed]
[8] Ge, R., Simonson, T.S., Gordeuk, V., Prchal, J.T. and McClain, D.A. (2015) Metabolic Aspects of High‐Altitude Adaptation in Tibetans. Experimental Physiology, 100, 1247-1255. [Google Scholar] [CrossRef] [PubMed]
[9] Boehm, F.J. and Zhou, X. (2022) Statistical Methods for Mendelian Randomization in Genome-Wide Association Studies: A Review. Computational and Structural Biotechnology Journal, 20, 2338-2351. [Google Scholar] [CrossRef] [PubMed]
[10] Keaton, J.M., Kamali, Z., Xie, T., et al. (2024) Genome-Wide Analysis in over 1 Million Individuals of European Ancestry Yields Improved Polygenic Risk Scores for Blood Pressure Traits. Nature Genetics, 56, 778-791.
[11] Zhao, C., Ma, T., Cheng, X., Zhang, G. and Bai, Y. (2024) Genome‐wide Association Study of Cardiometabolic Multimorbidity in the UK Biobank. Clinical Genetics, 106, 72-81. [Google Scholar] [CrossRef] [PubMed]
[12] Bowden, J., Spiller, W., Del Greco M, F., Sheehan, N., Thompson, J., Minelli, C., et al. (2018) Improving the Visualization, Interpretation and Analysis of Two-Sample Summary Data Mendelian Randomization via the Radial Plot and Radial Regression. International Journal of Epidemiology, 47, 2100. [Google Scholar] [CrossRef] [PubMed]
[13] Burgess, S. and Thompson, S.G. (2017) Interpreting Findings from Mendelian Randomization Using the MR-Egger Method. European Journal of Epidemiology, 32, 377-389. [Google Scholar] [CrossRef] [PubMed]
[14] Wu, D., Potluri, N., Lu, J., Kim, Y. and Rastinejad, F. (2015) Structural Integration in Hypoxia-Inducible Factors. Nature, 524, 303-308. [Google Scholar] [CrossRef] [PubMed]
[15] Lee, F.S. (2024) Hypoxia Inducible Factor Pathway Proteins in High-Altitude Mammals. Trends in Biochemical Sciences, 49, 79-92. [Google Scholar] [CrossRef] [PubMed]
[16] Beall, C.M., Cavalleri, G.L., Deng, L., et al. (2010) Natural Selection on EPAS1 (HIF2α) Associated with Low Hemoglobin Concentration in Tibetan Highlanders. Proceedings of the National Academy of Sciences of the United States of America, 107, 11459-11464.
[17] Lawrence, E.S., Gu, W., Bohlender, R.J., Anza-Ramirez, C., Cole, A.M., Yu, J.J., et al. (2024) Functional EPAS1/HIF2A Missense Variant Is Associated with Hematocrit in Andean Highlanders. Science Advances, 10, eadj5661. [Google Scholar] [CrossRef] [PubMed]
[18] 刘海云, 占诗梦, 彭淑红, 等. 葛根芩连汤对肥胖2型糖尿病前期胰岛素抵抗伴缺氧大鼠肾组织HIF-2α、EPO及GILUT4表达的影响[J]. 中药药理与临床, 2024, 40(1): 3-8.
[19] Taniguchi, C.M., Finger, E.C., Krieg, A.J., Wu, C., Diep, A.N., LaGory, E.L., et al. (2013) Cross-Talk between Hypoxia and Insulin Signaling through Phd3 Regulates Hepatic Glucose and Lipid Metabolism and Ameliorates Diabetes. Nature Medicine, 19, 1325-1330. [Google Scholar] [CrossRef] [PubMed]
[20] Brunt, J.J., Shi, S.Y., Schroer, S.A., Sivasubramaniyam, T., Cai, E.P. and Woo, M. (2014) Overexpression of HIF-2α in Pancreatic Β Cells Does Not Alter Glucose Homeostasis. Islets, 6, e1006075. [Google Scholar] [CrossRef] [PubMed]
[21] Moon, J., Riopel, M., Seo, J.B., Herrero-Aguayo, V., Isaac, R. and Lee, Y.S. (2022) HIF-2α Preserves Mitochondrial Activity and Glucose Sensing in Compensating Β-Cells in Obesity. Diabetes, 71, 1508-1524. [Google Scholar] [CrossRef] [PubMed]